Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
indiana blog main
indiana top stories
5
×
life sciences
national blog main
boston blog main
clinical trials
fda
boston top stories
eli lilly
europe blog main
europe top stories
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san francisco blog main
san francisco top stories
boulder/denver blog main
boulder/denver top stories
cancer
detroit blog main
detroit top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
aimmune therapeutics
allergy
alprazolam
amgen
anaphylaxis
andrew oxtoby
arena pharmaceuticals
avapritinib
What
drug
5
×
fda
5
×
approval
cancer
eli
friday
lilly
patients
therapy
won
acute
address
addresses
agency
aimmune
allergy
approved
approves
awarded
bid
blueprint
boehringer
carries
causes
certain
condition
decades
designed
developed
diabetes
eisai
expand
fallen
flags
genetic
giant
giving
higher
immunotherapy
incidence
Language
unset
5
×
Current search:
drug
×
unset
×
fda
×
" indiana top stories "
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
4 years ago
FDA Rejects Boehringer Ingelheim, Eli Lilly Drug for Type 1 Diabetes
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
4 years ago
FDA OKs Lilly’s Lasmiditan, First New Acute Migraine Drug in Decades